IRD · Opus Genetics, Inc.
$3.78
+0.07 (+1.89%)
At close · Aug 3
Market Cap
$301.98M
Shares
81.40M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-16 | — | |
| 8-K | 2026-06-16 | — | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-04-24 | 2026-04-21 | |
| 8-K | 2026-04-22 | 2026-04-20 | |
| 8-K | 2026-04-07 | 2026-04-01 | |
| 8-K | 2026-04-07 | 2026-04-02 | |
| DEF 14A | 2026-03-23 | 2026-04-20 | |
| 10-K | 2026-03-12 | 2025-12-31 | |
| 8-K | 2026-03-10 | — | |
| 8-K | 2026-02-19 | 2026-02-13 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2026-01-08 | — | |
| 8-K | 2025-12-19 | 2025-12-17 | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-06 | 2025-11-05 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-09-30 | — | |
| 8-K | 2025-09-02 | 2025-08-29 | |
| 8-K | 2025-08-25 | — | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-08-13 | — | |
| 8-K | 2025-07-23 | 2025-07-22 | |
| 8-K | 2025-06-26 | — | |
| 8-K | 2025-06-25 | — | |
| 8-K | 2025-06-23 | — | |
| 8-K | 2025-06-20 | 2025-06-13 | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-15 | — | |
| 8-K | 2025-05-01 | 2025-04-30 | |
| 8-K | 2025-04-04 | 2025-04-02 | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-03-31 | — | |
| 8-K | 2025-03-24 | 2025-03-21 | |
| 8-K | 2025-03-20 | — | |
| 8-K | 2025-03-20 | 2025-03-19 | |
| 8-K | 2025-03-04 | — | |
| 8-K | 2025-01-24 | 2025-01-17 | |
| 8-K | 2025-01-23 | — | |
| 8-K | 2025-01-14 | 2025-01-13 | |
| 8-K/A | 2025-01-07 | 2024-10-22 | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-10-22 | — | |
| 8-K | 2024-08-13 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-06-13 | 2024-06-11 | |
| 8-K | 2024-05-10 | — |
Showing 1–50 of 136 filings
Key facts
CIK
1228627
CUSIP
67577R102
13F (30d)
14 filings
14 filers
Visit website
Investor relations